When examined according to breast cancer sub-type, worse RFS of high expressers was observed in ER (Estrogen Receptor) positive cancers (Figure 8B and Figure 9B) but not in ER negative cases (Figure 8C and Figure 9C). This evidence concerns the gene ESR1 and cancer.